Dectrocel Healthcare and Research Information

At Dectrocel, our mission is simple and bold: to use AI to make healthcare more accessible and affordable — at scale. We are a next-generation healthtech company creating clinical-grade AI solutions that accelerate diagnostics, improve imaging accuracy, and expand access to care. Our tools integrate deep learning directly into imaging workflows, helping radiologists and clinicians deliver faster, smarter, and more equitable diagnoses. Our flagship product, DecXpert, is a CDSCO-approved, ISO 13485 certified AI tool for chest X-ray interpretation, trained on 1 million+ unique patient scans — the world’s largest dataset of its kind. It delivers radiologist-grade reports in under 30 seconds, and is trusted by institutions such as Adani Group, CURA Healthcare, and Apollo Hospitals. Our growing portfolio also includes: CT Thorax AI – rapid thoracic scan interpretation MY LGP Health App – symptom-based screening for Hepato-Pancreatic-Biliary (HPB) diseases using deep learning PET Cyclotron AI Solutions (coming soon) – bringing AI to advanced oncology imaging Clinically validated at SGPGI, India’s leading super-speciality teaching institute, our tools support time- and resource-strapped radiology teams, especially in underserved regions. Dectrocel was founded by a dynamic team from Harvard Medical School, IIT Kanpur, and the University of Queensland, and is a beneficiary of the Startup India Seed Fund. We are proudly supported by top incubators including IIT Mandi, Bimtech, and STPI, and backed by leading investors like Indian Angel Network (IAN), PadUp Ventures, and Value Angel Network. We are not just building products — we’re reimagining the future of radiology to ensure every scan leads to faster diagnosis, better decisions, and healthier lives.